摘要
目的:观察蒲地蓝消炎口服液治疗小儿手足口病的临床疗效。方法:选择门诊176例手足口病患儿随机分成两组,治疗组130例口服蒲地蓝消炎口服液;对照组46例口服利巴韦林颗粒。结果:两组疗效比较,治疗组显效率(57.5%)、总有效率(92.5%)均明显优于对照组(分别为19.4%,69.4%),差异有统计学意义(P<0.01);两组总病程、口腔溃疡好转时间比较差异有统计学意义(P<0.05);两组总热程、用药后热程、皮疹消退时间比较差异有统计学意义(P<0.01)。结论:蒲地蓝消炎口服液治疗手足口病疗效显著,预后良好,能缩短疗程,未见明显不良反应。
Objective: To evaluate the therapeutic effects of Pudilan Xiaoyan oral liquid in children with hand, foot and mouth disease (HFMD). Methods: One hundred and seventy-six patients with HFMD in our out-patient department were randomly divided into two groups. One hundred and thirty patients in the therapeutic group were treated with Pudilan Xiaoyan oral liquid; 46 patients in the control group were treated with oral ribavirin. Results: The marked effect rate and the total effective rate of the therapeutic group were significantly higher than those of the control group ( P 〈 0.01 ). The difference in disappearing of main symptom and sign, total course of disease, oral ulcer improvement time was significant (P 〈 0.05 ) between the therapeutic group and the control group. There was a significant difference in total length of fever time, length of fever time after treatment and deflorescence time between the therapeutic group and the control group (P 〈 0.01 ). Conclusions: Pudilan Xiaoyan oral liquid has a good therapeutic effect in children with HFMD, and shortened duration of HFMD with no complications and adverse reactions.
出处
《儿科药学杂志》
CAS
2009年第5期32-34,共3页
Journal of Pediatric Pharmacy
关键词
手足口病
蒲地蓝消炎口服液
利巴韦林
儿童
Hand, foot and mouth disease
Pudilan Xiaoyan oral liquid
Ribavirin
Children